Atara Biotherapeutics (ATRA) Net Income towards Common Stockholders (QoQ) (2013 - 2026)
Atara Biotherapeutics (ATRA) Net Income towards Common Stockholders (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.34% |
| Dec 31, 2025 | 21.26% |
| Sep 30, 2025 | -280.27% |
| Jun 30, 2025 | -93.72% |
| Mar 31, 2025 | 399.46% |
| Dec 31, 2024 | 42.06% |
| Sep 30, 2024 | -15.01% |
| Jun 30, 2024 | 40.01% |
| Mar 31, 2024 | 47.47% |
| Dec 31, 2023 | 13.39% |
| Sep 30, 2023 | 1.84% |
| Jun 30, 2023 | 4.90% |
| Mar 31, 2023 | -0.27% |
| Dec 31, 2022 | 11.32% |
| Sep 30, 2022 | -555.38% |
| Jun 30, 2022 | 120.96% |
| Mar 31, 2022 | 5.83% |
| Dec 31, 2021 | -10.50% |
| Sep 30, 2021 | -1.04% |
| Jun 30, 2021 | -6.97% |